Third-generation beta-blocker with vasorelaxant and alpha-adrenoceptor-blocking effects July 30, 1999
Inhibitors of 15-LO designed at Warner-Lambert, particularly useful for atherosclerosis July 30, 1999
Continuous infusion of toborinone preferable in heart failure developing after cardiac surgery July 27, 1999
Novel silent antagonist of vascular 5-HT1B-like receptors identified during collaboration July 26, 1999
Spironolactone-containing drug regimen: the new gold standard for treating heart failure July 21, 1999